Huang, Jane

Huang, Jane
	Affiliated Entities     Beigene, Ltd Prelude Therapeutics Inc. Proteon Therapeutics, Inc.

Add a document

Description
Summary
Document Type	Academic Paper Corporate Document - Internal Corporate Document - Public Court Document Equity Research Government Document - Federal Government Document - State Government Document - Local FBI File Public Records Request Response - FOIA Public Records Request Response - State Non-Profit Report Police Report White Paper
Document Date
Document Source
Source URL
File
	If you would like to be credited for contributing this document, make sure to sign in or sign up first. Once uploaded, your document may not be immediately visible to the public as we review each document for legal issues. Thanks for your patience!

Go Pro to view an analysis and graphs of case roles, types and more.

Filter By From To

	Date Filed	Venue	Case Number	Title	Party Type
	10/10/2023	Superior Court of California, County of Santa Clara	23CH011973	Adriano Tupe v. Jane Huang	Defendant
	6/15/2017	Superior Court of California, County of Santa Clara	17CV311839	Inna Zatulovsky v. Jane Huang, et al	Defendant
	4/9/2012	Superior Court of California, County of Santa Clara	2012-1-CV-222140	J. Huang v. K. Ho	Plaintiff
	5/6/2011	Superior Court of California, County of San Bernardino	CIVRS1104618	(cmplx) Calabrese Et Al V. Shea Homes Et Al	Plaintiff
	7/9/2004	United States Patent and Trademark Office	10888525	Disparate sales system integration and method	Applicant
	7/5/2000	Superior Court of California, County of Santa Clara	2000-1-CV-790897	HUANG v. TARGET CORPORATION	Plaintiff

6 Rows Total

Outside Counsel (11)

	Last Name	First Name	Middle Name	Firm	Location
	Berman	Brian		Alan Whitehurst
	Cousins	Patricia	M
	Hearn	Brian		Alan Whitehurst
	HERSHKOVITZ	ABRAHAM		Hershikovitz & Associates	Washington, DC
	Kim	Jae Youn		NOVICK, KIM & LEE, PLLC	Fairfax, VA
	Naghibi	Leila		Alan Whitehurst
	Nguyen	Dinh		Alan Whitehurst
	Novick	Harold	L.	nkllaw.com Law Firm Placeholder	Vienna, VA
	RZUCIDLO	EUGENE
	Scafetta	Joseph	A.	Oblon, Spivak, McClelland, Maier & Neustadt,...
	Zatulovsky	Inna		Inna Zatulovsky	San Francisco, CA

11 Rows Total

Filter By Form All Records 3 4 From To

	Date	Entity	Form Number	Description
	4/7/2025	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	2/5/2025	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	1/7/2025	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	10/7/2024	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	7/8/2024	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	6/10/2024	Proteon Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	4/8/2024	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	3/4/2024	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	1/8/2024	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	10/6/2023	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	6/8/2023	Proteon Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	4/6/2023	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	2/9/2023	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	6/9/2022	Proteon Therapeutics, Inc.	4	Statement of changes in beneficial ownership of securities
	5/4/2022	Prelude Therapeutics Inc.	4	Statement of changes in beneficial ownership of securities
	4/6/2022	Prelude Therapeutics Inc.	3	Initial statement of beneficial ownership of securities
	12/16/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	12/2/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	11/19/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	10/21/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	9/22/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	9/15/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	9/2/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	7/19/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	6/30/2021		4	Statement of changes in beneficial ownership of securities
	6/21/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	6/10/2021		4	Statement of changes in beneficial ownership of securities
	6/10/2021		3	Initial statement of beneficial ownership of securities
	6/9/2021		4	Statement of changes in beneficial ownership of securities
	6/2/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	5/3/2021		4	Statement of changes in beneficial ownership of securities
	3/31/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	3/2/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	2/2/2021	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	12/30/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	12/2/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	11/2/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	10/1/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	9/8/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	9/1/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	7/31/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	7/9/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	6/30/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	6/19/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	6/10/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	6/2/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	4/30/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	4/17/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	2/20/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities
	1/22/2020	Beigene, Ltd	4	Statement of changes in beneficial ownership of securities

71 Rows Total	Page 1 of 2 | Go To

	Date Recorded	Party	Role	Document Type	Document No.	Invention Title
	11/6/2024	Google LLC	Assignee	Application Publication	18766528 20240364441	Method For Identifying New Audiences For Content Of A Content Provider Method For Identifying New Audiences For Content Of A Content Provider
	8/20/2024	Beigene, Ltd.	Assignee	Application Publication	18524170 20240122932	Methods of Treating B-Cell Malignancy Using Bcl-2 Inhibitor Methods of Treating B-Cell Malignancy Using Bcl-2 Inhibitor
	7/22/2024	University Of Notre Dame Du Lac	Assignee	Application Publication	17936648 20230095339	Augmented Reality For Emergency Response Augmented Reality For Emergency Response
	4/5/2024	University Of Notre Dame Du Lac	Assignee	Application Publication Patent	17571449 20220253076 12038767	Configurator For Multiple User Emergency Response Drones Configurator For Multiple User Emergency Response Drones Configurator For Multiple User Emergency Response Drones
	10/28/2021	Beigene Switzerland GmbH	Assignee	Application Application Publication Publication	16766803 16766803 20200368237 20200368237	Treatment Of Indolent Or Aggressive B-cell Lymphomas Using A Combination... Treatment Of Indolent Or Aggressive B-cell Lymphomas Using A Combination...
	10/28/2021	Beigene Switzerland GmbH	Assignee	Application Application Publication Publication Patent Application	16766803 16766803 20200368237 20200368237 11786529 11786529	Treatment Of Indolent Or Aggressive B-cell Lymphomas Using A Combination... Treatment Of Indolent Or Aggressive B-cell Lymphomas Using A Combination... Treatment Of Indolent Or Aggressive B-cell Lymphomas Using A Combination... Treatment Of Indolent Or Aggressive B-cell Lymphomas Using A Combination... Treatment Of Indolent Or Aggressive B-cell Lymphomas Using A Combination...
	7/27/2021	Google LLC	Assignee	Application Publication Patent	17377215 20230020043 12034525	Method For Identifying New Audiences For Content Of A Content Provider Method For Identifying New Audiences For Content Of A Content Provider Method For Identifying New Audiences For Content Of A Content Provider
	11/17/2020	Google LLC	Assignee	Application Publication	16971253 20210397892	Personalized Data Model Utilizing Closed Data Personalized Data Model Utilizing Closed Data
	11/17/2020	Google LLC	Assignee	Application Publication Patent	16971253 20210397892 12045314	Personalized Data Model Utilizing Closed Data Personalized Data Model Utilizing Closed Data Personalized Data Model Utilizing Closed Data
	11/17/2020	Google LLC	Assignee	Application Publication Patent	16971253 20210397892 12079307	Personalized Data Model Utilizing Closed Data Personalized Data Model Utilizing Closed Data Personalized Data Model Utilizing Closed Data
	9/16/2005	Orion Ip, LLC	Assignee	Application Publication	10888525 20050144087	Disparate sales system integration and method Disparate sales system integration and method
	7/19/2000	Meritor Heavy Vehicle Technology, LLC	Assignee	Application Patent	09619734 6405109	Axle Misalignment Method For A Vehicle Axle Misalignment Method For A Vehicle

12 Rows Total

Huang, Jane has not been involved in any trademark assignment transactions in the PlainSite database.

Affiliated Entities

• Beigene, Ltd
• Prelude Therapeutics Inc.
• Proteon Therapeutics, Inc.

Incoming Payments

This individual has not disclosed any incoming payments from lobbying groups.

Outgoing Payments

This individual has not disclosed any outgoing payments to lobbying groups.